Bell Investment Advisors’s Dentsply Sirona XRAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$489 Buy
46
+6
+15% +$66 ﹤0.01% 1735
2026
Q1
$464 Hold
40
﹤0.01% 1778
2025
Q4
$458 Sell
40
-153
-79% -$1.8K ﹤0.01% 1770
2025
Q3
$2.45K Hold
193
﹤0.01% 1262
2025
Q2
$3.06K Buy
+193
New +$2.89K ﹤0.01% 1190
2024
Q3
Sell
-18
Closed -$449 1954
2024
Q2
$449 Sell
18
-14
-44% -$402 ﹤0.01% 1850
2024
Q1
$1.06K Hold
32
﹤0.01% 1588
2023
Q4
$1.14K Sell
32
-27
-46% -$857 ﹤0.01% 1550
2023
Q3
$2.02K Buy
59
+13
+28% +$494 ﹤0.01% 1266
2023
Q2
$1.84K Sell
46
-14
-23% -$557 ﹤0.01% 1341
2023
Q1
$2.36K Buy
60
+14
+30% +$514 ﹤0.01% 1173
2022
Q4
$1.47K Sell
46
-87
-65% -$2.62K ﹤0.01% 1442
2022
Q3
$4K Buy
133
+40
+43% +$1.37K ﹤0.01% 851
2022
Q2
$3K Buy
+93
New +$3.76K ﹤0.01% 1045
2021
Q4
$3K Sell
58
-31
-35% -$1.71K ﹤0.01% 1052
2021
Q3
$5K Buy
+89
New +$5.49K ﹤0.01% 751

Other funds holding XRAY

Bell Investment Advisors's XRAY Position: Q2 2026 in Review

Bell Investment Advisors increased its Dentsply Sirona (XRAY) stake by 15% in Q2 2026, buying an estimated $66 and bringing the position to 46 shares worth $489. The position accounts for ﹤0.01% of the portfolio, ranked #1735.

Bell Investment Advisors first reported a position in XRAY in Q3 2021 and has held it in 16 quarters since. The position peaked at $5K in Q3 2021. 373 funds tracked by Wall St. Rank hold XRAY as of Q2 2026.

  • Bell Investment Advisors held 46 shares of Dentsply Sirona worth $489 as of Q2 2026.
  • Bell Investment Advisors bought 6 Dentsply Sirona shares in Q2 2026, an estimated $66.
  • Dentsply Sirona made up ﹤0.01% of Bell Investment Advisors's portfolio in Q2 2026, its #1735 holding.
  • Bell Investment Advisors first reported a position in Dentsply Sirona in Q3 2021 and has held it in 16 quarters since.
  • Bell Investment Advisors's Dentsply Sirona position peaked at $5K in Q3 2021.
  • 373 funds tracked by Wall St. Rank held Dentsply Sirona as of Q2 2026.

Based on Bell Investment Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.